Myriad Genetics

Myriad Genetics discovers, develops, and commercializing novel therapies for the treatment of cancer.

Myrexis is a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer. Myrexis pipeline includes clinical and pre-clinical product candidates with distinct mechanisms of action and novel chemical structures that have the potential to be first-in-class and/or best-in-class therapeutics.